Search Results
Addressing Unmet Needs Among High-Risk Patients With ASCVD With Novel Lipid-Lowering Therapies
Innovative Lipid Management Strategies for ASCVD Risk Reduction
Beyond LDL: Assessing and Treating Residual ASCVD Risk | Marc-Andre Cornier, MD
Societal Implications: Addressing Unmet Needs in Cholesterol Management | Professor Henry Ginsberg
Dr Erin Bohula May - 'At the limits of lipid management – statins to PCSK9 inhibitors'
Targeted Strategies in Lipid Lowering Therapy Where Do We Stand Now
New Frontiers for Lipid Lowering Treatment
OfficePerspectives PCSK9
The new decade in ASCVD
Lipids and Your Heart with Dr. Carolyn Burns at Virginia Cardiovascular Specialists
Alert! Can clinical decision support tools ‘PROMPT’ better quality ASCVD care?
ACC 22: Secondary Analysis of CANTOS Finds LDL & HDL Predict Residual Risk of Atherosclerotic Events
